Salix Pharmaceuticals' Gastrointestinal Health Scholars Awards Program funds 10 scholarships a year -- six undergraduate, three graduate, and one for a working or single parent -- worth up to $10,000 each, for U.S. citizens diagnosed with and treated by a licensed provider for a gastrointestinal condition such as IBS or ulcerative colitis. Applicants submit a roughly 500-word essay on how the condition has affected their life and their provider's role, two signed letters of recommendation, and a signed medical statement form; the award is not need-based. The 2026 cycle ran February 11 through May 6.
DemographicsMust be a U.S. citizen diagnosed with and treated for a gastrointestinal condition (e.g. IBS, ulcerative colitis) by a licensed provider; healthcare professionals, their families, and Salix employees/relatives are ineligible.
Up to $10,000 per recipient across 10 awards: 6 undergraduate, 3 graduate, and 1 working/single-parent award.